Back to Trades
Snellgrove Darren
SVP Chief Financial OfficerCIK 0002137401
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Snellgrove Darren, SVP, Chief Financial Officer, accounts for 2 disclosed filings worth $9.8M, all concentrated in HALOZYME THERAPEUTICS, INC. (HALO), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jul 2 | HALO HALOZYME THERAPEUTICS, INC. | Snellgrove Darren | SVP, Chief Financial Officer | Award | $9.8M |
| Jun 9 | HALO HALOZYME THERAPEUTICS, INC. | Snellgrove Darren | SVP, Chief Financial Officer | Other | $0 |
2 filings